Abel Hall LLC’s Savara SVRA Stock Holding History

Abel Hall LLC’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,680	Closed	-$88.5K	–	962
2025 Q4	$88.5K	Buy	+14,680	New	+$71.9K	0.02%	620

Other funds holding SVRA

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Abel Hall LLC's SVRA Position: Q1 2026 in Review

Abel Hall LLC sold out of Savara (SVRA) in Q1 2026, closing a stake of 14,680 shares — an estimated $88.5K sold.

Abel Hall LLC first reported a position in SVRA in Q4 2025 and held it in 1 quarter. The position peaked at $88.5K in Q4 2025. 185 funds tracked by Wall St. Rank hold SVRA as of Q1 2026.

Abel Hall LLC reported no remaining Savara position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 14,680 Savara shares in Q1 2026, an estimated $88.5K.
Abel Hall LLC first reported a position in Savara in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's Savara position peaked at $88.5K in Q4 2025.
185 funds tracked by Wall St. Rank held Savara as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.